NCT05221606

Brief Summary

Nurse AMIE 3.0 is testing the effectiveness of an electronic symptom management system on overall survival in people with stage 3 and 4 cancer who live in rural areas.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
344

participants targeted

Target at P75+ for not_applicable cancer

Timeline
10mo left

Started May 2022

Longer than P75 for not_applicable cancer

Geographic Reach
1 country

8 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress83%
May 2022Mar 2027

First Submitted

Initial submission to the registry

January 27, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 3, 2022

Completed
3 months until next milestone

Study Start

First participant enrolled

May 3, 2022

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2027

Last Updated

March 10, 2026

Status Verified

March 1, 2026

Enrollment Period

4.8 years

First QC Date

January 27, 2022

Last Update Submit

March 9, 2026

Conditions

Keywords

supportive caredigital healthphysical activitysymptom management

Outcome Measures

Primary Outcomes (1)

  • Survival

    Survival of each participant will be monitored through the electronic medical records throughout the course of the study. After the study is completed, we will monitor survival using the National Death Index from the Centers for Disease Control and Prevention (CDC).

    through study completion, an average of two years

Secondary Outcomes (11)

  • Change in Health-Related Quality of Life measured using the 36-Item Short Form Health Survey (SF-36)

    baseline, month 6, month 12, month 18, month 24

  • Change in Physical Function measured using the Short Physical Performance Battery (SPPB)

    baseline, month 6, month 12, month 18, month 24

  • Change in Symptoms measured using the Patient-Reported Outcomes Measurement Information System: The PROMIS ®-Preference (PROPr)

    baseline, month 1, month 3, month 6, month 9, month 12, month 18, month 24

  • Cost-Effectiveness measured using a self-report survey of Healthcare Utilization

    baseline

  • Cost-Effectiveness measured using a self-report survey of Healthcare Utilization

    month1

  • +6 more secondary outcomes

Study Arms (2)

Nurse AMIE Supportive Care Intervention

EXPERIMENTAL

Participants in the intervention arm will receive the computer tablet with the Nurse AMIE program. Nurse AMIE will assess their symptoms daily and provide an intervention to help manage their symptoms.

Behavioral: Nurse AMIE

Usual Care

ACTIVE COMPARATOR

Participants in the usual care arm will receive a book with some supportive care educational materials and recommendations.

Behavioral: Usual Care

Interventions

Nurse AMIEBEHAVIORAL

Supportive Care Platform (behavioral interventions that are offered based on answers to daily symptom rating questions). Interventions offered include walking, balance, strength exercise, guided relaxation, mindfulness, CBT, DBT, soothing music.

Nurse AMIE Supportive Care Intervention
Usual CareBEHAVIORAL

Binder of written supportive care materials

Usual Care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient receiving care for their cancer
  • Age: 18+ years of age
  • Has stage 3 or 4 cancer, or an unstaged cancer that is considered 'advanced' (greater than stage 2) by their treating oncologist
  • Must be within six months of initiation of pharmacologic or radiation treatment, for curative or palliative purposes, from a medical or radiation oncologist
  • Clinician-rated ECOG function of 0-3
  • Lives in a county with RUCC code 4 - 9 and/or zip code with RUCA code 4-10
  • Has access to personal device capable of receiving telephone calls for study facilitator check-ins
  • Fluent in written and spoken English
  • Sufficient vision/hearing to interact with the tablet and study staff
  • Clinician-defined life expectancy of 6 months or more

You may not qualify if:

  • Patients with medical or psychiatric conditions documented in the medical record (beyond cancer, its treatments, and its symptoms) that would impair our ability to test study hypotheses (e.g. psychotic disorders, dementia, inability to give informed consent, or follow study instructions).
  • Patients who are participating in any other supportive care or behavioral intervention studies.
  • Non-English speaking patients will be excluded, as they represent less than 2% of the population targeted.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (8)

UPMC-Butler

Butler, Pennsylvania, 16001, United States

Location

UPMC - Greenville

Greenville, Pennsylvania, 16125, United States

Location

Penn State Hershey Medical Center

Hershey, Pennsylvania, 17033, United States

Location

UPMC - Indiana

Indiana, Pennsylvania, 15701, United States

Location

UPMC - New Castle

New Castle, Pennsylvania, 16105, United States

Location

UPMC - Northwest

Seneca, Pennsylvania, 16346, United States

Location

Mount Nittany Medical Center

State College, Pennsylvania, 16803, United States

Location

West Virginia University

Morgantown, West Virginia, 26506, United States

Location

Related Publications (1)

  • Schmitz KH, Baker S, Werts-Pelter SJ, Doerksen S, Patterson CG, Ahmed M, Scalise R, Vincent A, Desroches C, Sobolewski M, Celebre R, Garrett S, Stout N, Calo WA, Fisher S, Schleicher E, Gordon B, Kumar P. Nurse AMIE randomized controlled trial to address symptom management among rural advanced Cancer patients: Addressing malignancies in everyday life. Contemp Clin Trials. 2025 Aug;155:108005. doi: 10.1016/j.cct.2025.108005. Epub 2025 Jul 10.

MeSH Terms

Conditions

NeoplasmsMotor Activity

Condition Hierarchy (Ancestors)

Behavior

Study Officials

  • Kathryn Schmitz, PhD

    University of Pittsburgh / UPMC

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

January 27, 2022

First Posted

February 3, 2022

Study Start

May 3, 2022

Primary Completion (Estimated)

March 1, 2027

Study Completion (Estimated)

March 1, 2027

Last Updated

March 10, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations